The open peptide
reference database

Semaglutide is a GLP-1 receptor agonist primarily used for managing type 2 diabetes and aiding in weight loss. It works by mimicking the GLP-1 hormone, which enhances insulin secretion, reduces glucagon release, and slows gastric emptying, leading to reduced appetite. Available as both a subcutaneous injection and an oral tablet, semaglutide offers flexibility in administration. Its long half-life allows for weekly dosing, making it a convenient option for patients.

Liraglutide is a GLP-1 receptor agonist primarily used for weight management and Type 2 diabetes control. It mimics the action of the GLP-1 hormone, enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying. This results in increased satiety and reduced appetite, making it an effective tool for managing weight and blood glucose levels. Approved by the FDA in 2010, it is administered via subcutaneous injection and is known for its favorable safety profile when used as prescribed.

Glutathione, a tripeptide composed of glutamine, cysteine, and glycine, is a powerful antioxidant that plays a crucial role in protecting cells from oxidative stress and toxins. It is widely used for its anti-aging properties, liver support, and skin health benefits. Available in various forms, including oral, intravenous, and topical, it is a popular choice for those seeking to enhance their overall health and detoxification processes.

Oxytocin, a well-known neuropeptide, plays a crucial role in reproductive and social behaviors. It is primarily used in medical settings to induce labor and control postpartum hemorrhage. Additionally, oxytocin has garnered interest for its potential effects on social bonding and behavior, making it a subject of research in neurological and psychological contexts. Its rapid onset of action and short half-life make it effective for acute interventions.

Insulin is a critical hormone for the regulation of glucose metabolism, primarily used in the management of diabetes mellitus. It facilitates the uptake of glucose into cells, thereby lowering blood sugar levels. Insulin therapy is essential for individuals with Type 1 diabetes and often used in Type 2 diabetes when other treatments are insufficient. Available in various formulations, insulin can be tailored to meet individual patient needs, ensuring effective blood glucose control.

Insulin glargine is a long-acting insulin analog used primarily in the management of type 1 and type 2 diabetes. It provides a steady release of insulin over an extended period, typically 24 hours, which helps maintain stable blood glucose levels. As a cornerstone in diabetes management, it is often prescribed alongside lifestyle modifications and other medications to optimize glycemic control. Its long duration of action and predictable pharmacokinetic profile make it a preferred choice for many patients requiring basal insulin therapy.